A methodological framework for drug development in rare diseases

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1172

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A methodological framework for drug development in rare diseases ; volume:9 ; number:1 ; day:18 ; month:11 ; year:2014 ; pages:1-10 ; date:12.2014
Orphanet journal of rare diseases ; 9, Heft 1 (18.11.2014), 1-10, 12.2014

Contributor: Nony, Patrice
Kurbatova, Polina
Bajard, Agathe
Malik, Salma
Castellan, Charlotte
Chabaud, Sylvie
Volpert, Vitaly
Eymard, Nathalie
Kassai, Behrouz
Cornu, Catherine
SpringerLink (Online service)

DOI: 10.1186/s13023-014-0164-y

URN: urn:nbn:de:1111-2016050126003

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Nony, Patrice
Kurbatova, Polina
Bajard, Agathe
Malik, Salma
Castellan, Charlotte
Chabaud, Sylvie
Volpert, Vitaly
Eymard, Nathalie
Kassai, Behrouz
Cornu, Catherine
SpringerLink (Online service)

Other Objects (12)

Rare diseases and orphan drugs: Latvian story

Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases

One drug to treat many diseases: unlocking the economic trap of rare diseases

Dose-finding studies in drug development for rare genetic diseases

Akten

Rare Diseases Network

European Reference networks for rare diseases: what is the conceptual framework?

Arbeitspapier

Methodological framework for cluster analyses

Large-scale computational drug repositioning to find treatments for rare diseases

Targeting shared molecular etiologies to accelerate drug development for rare diseases

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

Sustainable rare diseases business and drug access: no time for misconceptions

Rare diseases and orphan drugs: Latvian story

Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases

One drug to treat many diseases: unlocking the economic trap of rare diseases

Dose-finding studies in drug development for rare genetic diseases

Akten

Rare Diseases Network

European Reference networks for rare diseases: what is the conceptual framework?

Arbeitspapier

Methodological framework for cluster analyses

Large-scale computational drug repositioning to find treatments for rare diseases

Targeting shared molecular etiologies to accelerate drug development for rare diseases

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

Sustainable rare diseases business and drug access: no time for misconceptions

Rare diseases and orphan drugs: Latvian story

Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases

One drug to treat many diseases: unlocking the economic trap of rare diseases

Dose-finding studies in drug development for rare genetic diseases

Akten

Rare Diseases Network

European Reference networks for rare diseases: what is the conceptual framework?

Arbeitspapier

Methodological framework for cluster analyses

Large-scale computational drug repositioning to find treatments for rare diseases

Targeting shared molecular etiologies to accelerate drug development for rare diseases

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

Sustainable rare diseases business and drug access: no time for misconceptions

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A methodological framework for drug development in rare diseases

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Rare diseases and orphan drugs: Latvian story

Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases

One drug to treat many diseases: unlocking the economic trap of rare diseases

Dose-finding studies in drug development for rare genetic diseases

Rare Diseases Network

European Reference networks for rare diseases: what is the conceptual framework?

Methodological framework for cluster analyses

Large-scale computational drug repositioning to find treatments for rare diseases

Targeting shared molecular etiologies to accelerate drug development for rare diseases

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

Sustainable rare diseases business and drug access: no time for misconceptions

Rare diseases and orphan drugs: Latvian story

Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases

One drug to treat many diseases: unlocking the economic trap of rare diseases

Dose-finding studies in drug development for rare genetic diseases

Rare Diseases Network

European Reference networks for rare diseases: what is the conceptual framework?

Methodological framework for cluster analyses

Large-scale computational drug repositioning to find treatments for rare diseases

Targeting shared molecular etiologies to accelerate drug development for rare diseases

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

Sustainable rare diseases business and drug access: no time for misconceptions

Rare diseases and orphan drugs: Latvian story

Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR

RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases

One drug to treat many diseases: unlocking the economic trap of rare diseases

Dose-finding studies in drug development for rare genetic diseases

Rare Diseases Network

European Reference networks for rare diseases: what is the conceptual framework?

Methodological framework for cluster analyses

Large-scale computational drug repositioning to find treatments for rare diseases

Targeting shared molecular etiologies to accelerate drug development for rare diseases

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

Sustainable rare diseases business and drug access: no time for misconceptions

Related objects

Reset password